East Ventures Leads Series A Funding for Biotech Startup Nusantics
Officially announced the Venture Advisor, Triawan Munaf as a commissioner at Nusantics
Nusantics biotech startup announced series A funding led by East Ventures with an undisclosed value. Less than a year ago, East Ventures took the lead in seed funding for this startup managed by Sharlini Eriza Putri.
East Ventures decided to reinvest because these startups have managed to grow due to their fast response to the disruption caused by the Covid-19 pandemic. Nusantics utilizes its capabilities in microbiome research to develop two generations of PCR-based Covid-19 test kits with high levels of sensitivity and specificity.
The test kit is capable to detect various mutations of the Coronavirus in Indonesia, including a virus strain that recently became an epidemic in the UK. The first generation test kits have been distributed to 19 provinces as part of the Indonesia PASTI BISA movement in collaboration with the Agency for the Assessment and Application of Technology (BPPT).
Not ready to subscribe yet? Purchase and access this article